Notably, the hepatic fat content and inflammation are increased by PNPLA3 and TM6SF2, lipid metabolism genes, in all NAFLD disease stages [14]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.